Transcenta Among Chinese Biotechs Raising Funds Through Public Offerings, Private Financings
Healthy Investment In-Flow Continues
Executive Summary
A combined $447.2m are raised through a Hong Kong initial public offering (IPO) and venture capital and private equity deals.